Aehr Test Systems (AEHR)
NasdaqCM · Price as of · Nasdaq Real Time Price
- Profitability0/20
Losing money: $-7.1M net income over the last four reported quarters. Revenue over the last four reported quarters was $50.0M, down 17% from $59.9M the year before.
- Insider buying vs selling11/20
Insiders are sellers only: 18 sells worth $17.3M, no open-market buys, across the last 20 Form 4s. Routine executive selling is common, so this is only a mild negative. Separately, 1 new 5%+ stake disclosure (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings6/15
Share count up 9.0% in a year plus 2 offering-related filings. Real dilution. One nuance: offerings raise cash that can fund real growth. The score docks the certain near-term dilution; if the spending pays off, it shows up later in the profitability component.
- Analysts4
- Implied upside+60.9%
- Target range$110.00 to $175.00
- EPS expected$0.09 +833%
- A year ago$0.01
- Revenue expected$26.6M +143%
- Estimate range$0.07 to $0.11
AEHR closed at $80.81 on Aug 28, up 5.1% since Jul 30. Chart read: price above the 200-day moving average but below the 50-day; the 50-day is above the 200-day (uptrend structure); trading at 49% of the 52-week range ($19.40 to $145.61).
Insider buying and selling at Aehr Test Systems (AEHR)
The most recent Form 4 on record for Aehr Test Systems (AEHR) is August 12, 2026, when Gayn Erickson, President and CEO, sold $5.2M of stock. Nothing in the filing ties this one to a pre-arranged plan, so it was the filer's own call.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Gayn Erickson · President and CEO | Sell | $5.2M | August 12, 2026 | Own call |
| Geoffrey Gates Scott · Director | Sell | $2.6M | August 12, 2026 | Own call |
| Howard T Slayen · Director | Sell | $2.2M | August 4, 2026 | Own call |
| Alberto Salamone · EVP, PPBI BUSINESS | Sell | $2.8M | April 20, 2026 | Own call |
| Geoffrey Gates Scott · Director | Sell | $5.7M | April 21, 2026 | Own call |
Filed notices to sell
A Form 144 is filed beforean insider sells restricted stock. The Form 4 reporting the completed trade isn't due until two business days after the sale, so these land first. They are intentions, not transactions.
| Insider | Value | Filed | Status | Type |
|---|---|---|---|---|
| ROGERS VERNON · Officer | $574,217 | August 17, 2026 | Executed | Vested shares |
| POSEDEL RHEA J · Director | $836,220 | August 14, 2026 | Executed | Vested shares |
| ROGERS VERNON · Officer | $273,000 | August 14, 2026 | Not yet reported | Vested shares |
| SLAYEN HOWARD T · Director | $753,911 | August 14, 2026 | Executed | Own call |
| SALAMONE ALBERTO · Officer | $1.2M | August 13, 2026 | Executed | Vested shares |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | August 18, 2026 | PRIMARY DOCUMENT |
| 144 | August 17, 2026 | View on EDGAR |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| 4 | August 14, 2026 | PRIMARY DOCUMENT |
| SCHEDULE 13G/A | August 14, 2026 | View on EDGAR |
| 144 | August 14, 2026 | View on EDGAR |
| 144 | August 14, 2026 | View on EDGAR |
Aehr Test Systems news
All 8 articles
Aehr (AEHR) is up over 500% on the year, and five insiders just sold $11.15 million without a trading plan
On Aug. 12, five Aehr insiders including the CEO, the COO and the company's founder sold 85,130 shares for $11.15 million, and every one of them picked the date without a trading plan.
Aehr Test Systems (AEHR) director bought 20,000 shares at $15.50. He just filed to sell the same block near $109.
Fourteen insiders filed notices to sell stock on Tuesday. Thirteen were selling shares the company gave them. The fourteenth, a director at Aehr Test Systems, was selling 20,000 shares he bought himself at $15.50 two years ago.
Articles that mention Aehr Test Systems without it being the main subject.
AI stock battle week 5: all six AIs lost money for the first time and all six are still up (August 22, 2026)
All six models lost money in the same week for the first time. Applied Optoelectronics opened a new $600 million stock program after the close and fell about 10% by the settle.
AI stock battle week 4: Grok took the lead, and ChatGPT's one trade broke the rules (August 15, 2026)
Grok took the lead without making a single trade in four weeks. ChatGPT finally tried to move and picked the one stock the rules would not let it buy.
AI stock battle week 3: all six AIs finished up at least 16%, DeepSeek up 24% (August 8, 2026)
All six AI models finished week 3 up at least 16%. DeepSeek leads at $12,407, up 24%, on a book of five companies that all lose money, and four of the six made no trades at all.
Frequently asked questions
When does AEHR report earnings?
Aehr Test Systems (AEHR) is scheduled to report quarterly results on October 8, 2026, after the close. The 3-analyst consensus is $0.09 per share on revenue of $26.6M for the quarter ending August 31, 2026, against $0.01 and $11.0M a year earlier.
What do analysts expect for AEHR?
4 analysts cover Aehr Test Systems (AEHR). The consensus rating is Strong buy. The average price target is $130.00, in a range of $110.00 to $175.00.
Are insiders buying or selling AEHR?
We track Form 4 filings for Aehr Test Systems (AEHR). The activity listed on this page shows 5 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see AEHR SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed August 18, 2026.